Literature DB >> 19758315

Signal transducer and activator of transcription 3 upregulates interleukin-8 expression at the level of transcription in human melanoma cells.

Masahiro Oka1, Masanobu Sakaguchi, Taro Okada, Hiroshi Nagai, Michitaka Ozaki, Toyo Yoshioka, Hiroshi Inoue, Naofumi Mukaida, Ushio Kikkawa, Chikako Nishigori.   

Abstract

Many melanoma cells continuously produce interleukin-8 (IL-8). The involvement of signal transducer and activator of transcription 3 (STAT3) in the constant production of IL-8 in melanoma cells was examined. The level of IL-8 production correlated well with that of the phosphorylated (activated) STAT3 in six human melanoma cell lines. Introduction of the constitutively activated form of STAT3 (STAT3-C) into WM35 melanoma cells, that show low levels of IL-8 and phosphorylated STAT3, enhanced IL-8 production. Knockdown of STAT3 suppressed IL-8 production in WM1205Lu cells that contain a high level of IL-8 accompanied by STAT3 phosphorylation. Introduction of STAT3-C markedly increased the luciferase activity in WM1205Lu cells transfected with reporter vectors linked to the 5'-flanking region of the IL-8 gene from -546 to +44 base pair (bp) and from -272 to +44 bp, but not in cells expressing reporter plasmids from -133 to +44 bp and from -98 to +44 bp. These results indicate that the upregulation of IL-8 production is caused by constitutive STAT3 activation at the level of gene transcription in melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19758315     DOI: 10.1111/j.1600-0625.2009.00972.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  6 in total

1.  STAT3 silencing enhances the efficacy of the HSV.tk suicide gene in gastrointestinal cancer therapy.

Authors:  Ye-Hyeon Ahn; Hwajung Yi; Ji-Young Shin; Kang-Duck Lee; Seung-Pil Shin; Sang-Jin Lee; Jaewhan Song; Kyung-Hee Chun
Journal:  Clin Exp Metastasis       Date:  2012-02-17       Impact factor: 5.150

Review 2.  Current and future trials of targeted therapies in cutaneous melanoma.

Authors:  Matthew S Evans; Subbarao V Madhunapantula; Gavin P Robertson; Joseph J Drabick
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 3.  Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?

Authors:  Katie E O'Sullivan; John V Reynolds; Ciara O'Hanlon; Jacintha N O'Sullivan; Joanne Lysaght
Journal:  J Gastrointest Cancer       Date:  2014-03

4.  Stat3 mediates expression of autotaxin in breast cancer.

Authors:  Janeen Azare; Ashley Doane; Kenneth Leslie; Qing Chang; Marjan Berishaj; Jennifer Nnoli; Kevin Mark; Hikmat Al-Ahmadie; William Gerald; Maryam Hassimi; Agnes Viale; Mary Stracke; David Lyden; Jacqueline Bromberg
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

5.  IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.

Authors:  Puja Kachroo; Mi-Heon Lee; Ling Zhang; Felicita Baratelli; Gina Lee; Minu K Srivastava; Gerald Wang; Tonya C Walser; Kostyantyn Krysan; Sherven Sharma; Steven M Dubinett; Jay M Lee
Journal:  J Exp Clin Cancer Res       Date:  2013-11-25

6.  17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines.

Authors:  Mariusz L Hartman; Magdalena Rogut; Aleksandra Mielczarek-Lewandowska; Michal Wozniak; Malgorzata Czyz
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.